SCHEMBL22309336

SCHEMBL22309336

CC1(C)c2ccccc2-c2cc(-c3nc(-c4ccccc4)nc(-c4cccc(-c5cccc(-c6cc(-c7ccc8c(c7)oc7c9ccccc9ccc87)nc(-c7ccccc7)n6)c5)c4)n3)ccc21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.35
MAPT P10636 5/20 0.35
HPGD P15428 5/20 0.35
KDM4E B2RXH2 4/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
LMNA P02545 2/20 0.35
GLA P06280 1/20 0.35
PRKDC P78527 2/20 0.32
CYP1A1 P04798 7/20 0.32
CYP1A2 P05177 7/20 0.32
CYP1B1 Q16678 7/20 0.32
ABCC1 P33527 3/20 0.32
ABCG2 Q9UNQ0 3/20 0.32
TP53 P04637 2/20 0.32
TSHR P16473 2/20 0.32
MAPK1 P28482 2/20 0.32
HSD17B10 Q99714 2/20 0.32
ABCB1 P08183 2/20 0.32
PDE5A O76074 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22308991 1.00 ALDH1A1 (0.35) ALDH1A1MAPTHPGDKDM4EMEN1
SCHEMBL22308863 0.95 ALDH1A1 (0.34) ALDH1A1MAPTHPGDKDM4EMEN1
SCHEMBL22309365 0.95 ALDH1A1 (0.34) ALDH1A1MAPTHPGDKDM4EMEN1
SCHEMBL27101074 0.95 ALDH1A1 (0.34) ALDH1A1MAPTHPGDKDM4EMEN1
SCHEMBL22308637 0.94 ALDH1A1 (0.35) ALDH1A1MAPTHPGDKDM4EMEN1
SCHEMBL22308684 0.91 ALDH1A1 (0.35) ALDH1A1MAPTHPGDKDM4EMEN1
SCHEMBL22308676 0.91 KMT2A (0.39) ALDH1A1MAPTHPGDKDM4EMEN1
SCHEMBL22309584 0.91 KMT2A (0.39) ALDH1A1MAPTHPGDKDM4EMEN1
SCHEMBL22308990 0.91 KMT2A (0.39) ALDH1A1MAPTHPGDKDM4EMEN1
SCHEMBL22309329 0.90 ALDH1A1 (0.32) ALDH1A1MAPTHPGDKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11917910-B2 Organic compound and organic electroluminescent device using the same SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2024-02-27 US disclosed
US-11917910-B2 Organic compound and organic electroluminescent device using the same SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2024-02-27 US disclosed
US-20200251659-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME DOOSAN CORPORATION (KR) 2020-08-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200251659-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME VDAC1, OR10J3, PIEZO1 ALDH1A1 644/4885MAPT 660/4885HPGD 3640/4885
US-11917910-B2 Organic compound and organic electroluminescent device using the same VDAC1, OR10J3, PIEZO1 ALDH1A1 644/4885MAPT 660/4885HPGD 3640/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.